ArticleFuture oncology (London, England)Published
Burden of illness among patients with relapsed or refractory multiple myeloma, and eligible for B-cell maturation antigen-targeted therapies
Regional connection
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
- Institution
- Johnson & Johnson
- County
- Montgomery County
Publication record
- Type
- Article
- Venue
- Future oncology (London, England)
- Published
- Topic
- Public health
- Subject terms
- Humans; Multiple Myeloma; Neoplasm Recurrence, Local; Hospitalization; Retrospective Studies; Drug Resistance, Neoplasm; Cost of Illness; Adult; Aged; Aged, 80 and over; Middle Aged; Health Care Costs
- PubMed ID
- 40471555
- PubMed Central ID
- PMC12239814
- Open access
- Yes, open
- Added to directory
- Source checked